儿童斑秃甲状腺功能筛查指南
该研究通过单中心回顾性病历回顾,分析298例0-21岁斑秃患儿的甲状腺功能,发现20%存在甲状腺异常,其中甲状腺功能减退最常见(49%),桥本甲状腺炎为主要原因(41%)。结论建议仅对有唐氏综合征、特应性病史、甲状腺疾病家族史或甲状腺功能异常临床线索的斑秃患儿进行常规甲状腺功能筛查。
要点
- 20%的斑秃患儿甲状腺功能检测异常,甲状腺功能减退最常见。
- 唐氏综合征、特应性病史和甲状腺疾病家族史与甲状腺异常显著相关。
- 不建议对所有斑秃患儿常规筛查甲状腺功能,应限于高危人群。
核心结论
- 常规甲状腺功能筛查应仅限于有唐氏综合征病史、特应性病史、甲状腺疾病家族史或临床发现(甲状腺肿)提示潜在甲状腺功能异常的斑秃患者。
研究设计与样本
- 单中心回顾性病历回顾,纳入2008年1月1日至2016年1月1日期间在三级转诊医疗中心门诊儿科皮肤科诊所就诊的298例0-21岁斑秃患者。
主要发现
- 59例(20%)患者甲状腺检测结果异常,其中甲状腺功能减退29例(49%),桥本甲状腺炎24例(41%),Graves病所致甲状腺功能亢进12例(20%),亚临床甲状腺功能障碍7例(12%)。
- 斑秃模式包括斑片状(68%)、蛇行状(13%)、全秃(9%)和普秃(10%);严重程度按头皮脱发百分比分为轻度(30.2%)、中度(32.9%)和重度(36.9%)。
- 年龄、病程、脱发模式和自身免疫性疾病诊断与甲状腺异常无显著关联,而唐氏综合征个人史(P = .004)、特应性病史(P = .009)和甲状腺疾病家族史(P = .001)有显著关联。
关键数值与推荐
- 推荐对具有唐氏综合征病史、特应性病史、甲状腺疾病家族史或临床发现(甲状腺肿)提示潜在甲状腺功能异常的斑秃患者进行常规甲状腺功能筛查。
临床怎么用
- 临床实践中应避免对所有儿童斑秃患者常规筛查甲状腺功能,仅对具备上述高危因素者进行针对性筛查,以减少医疗费用和不必要的检查。
局限性
- 本研究为单中心回顾性病历回顾,可能存在选择偏倚和信息偏倚,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The incidence of thyroid disease in children with alopecia areata (AA) has been widely studied with no consensus on whether a true association with AA exists. In addition, screening practices for thyroid dysfunction in children with AA vary widely among clinicians. OBJECTIVE: To reduce health care costs, eliminate unnecessary testing, and standardize clinical practices, we sought to characterize thyroid function in children with AA to establish guidelines for screening. DESIGN, SETTING, AND PARTICIPANTS: A single-site retrospective medical chart review was carried out in an outpatient pediatric dermatology clinic in a tertiary referral medical center between January 1, 2008 and January 1, 2016. The study included 298 patients (ages 0-21 years) who received a clinical diagnosis of AA and underwent thyroid function tests. MAIN OUTCOMES AND MEASURES: Age at diagnosis of AA, duration of disease, severity, location, and type were documented. Past medical history and family medical history of patients were also recorded. Results of laboratory tests including thyrotropin (formerly thyroid-stimulating hormone [TSH]), free T4 (FT4), triiodothyronine (T3), thyroid peroxidase antibodies (TPO-Abs), and thyroglobulin antibodies (Tg-Abs). RESULTS: During the 8-year period, 298 patients with AA had thyroid function screening. Of those with thyroid screening, patterns of AA included patchy (68%), ophiasis (13%), totalis (9%), and universalis (10%). Severity was determined by percentage of hair loss on the scalp and were divided into mild (30.2%), moderate (32.9%), and severe (36.9%). A total of 59 (20%) patients had abnormalities on thyroid testing results. In this group of patients, hypothyroidism was the most frequent finding 29 (49%), with Hashimoto thyroiditis being the most common cause(24 [41%]). Other abnormalities included hyperthyroidism secondary to Grave disease (12 [20%]) and subclinical thyroid dysfunction (7 [12%]). Whereas age, duration of disease, pattern of alopecia, and diagnosis of autoimmune diseases had no significant association with abnormal thyroid findings, a personal history of Down syndrome (P = .004), atopy (P = .009), and family history of thyroid disease (P = .001) did. CONCLUSIONS AND RELEVANCE: We recommend that routine thyroid function screening should be restricted to AA patients with a medical history of Down syndrome, personal history of atopy, a family history of thyroid disease, or clinical findings (goiter) suggestive of potential thyroid dysfunction in the individual patient.
引用
- Patel D, Li P, Bauer AJ, et al. Screening Guidelines for Thyroid Function in Children With Alopecia Areata. JAMA Dermatol. 2017. PMID: 28973128. doi:10.1001/jamadermatol.2017.3694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。